Our son, Clevon, was recently diagnosed with an autoimmune disease in which his immune system is attacking the insulin-producing cells in his pancreas. Clevon is the kind of kid who always wants to do the right thing, make others happy, and give his best — on and off the field.

Because we caught this early, he qualifies for Tzield, a groundbreaking FDA-approved treatment available only during a small window for children identified early enough.

Tzield is a 14-day infusion treatment and comes with significant out-of-pocket costs, even with insurance. Between treatment, travel, and medical expenses, the financial burden is more than we can manage alone.

This treatment gives Clevon a rare chance to protect his health during a critical window, time that could allow him to keep being himself longer before Type 1 diabetes takes more from him.

We are doing everything we can to give Clevon the best possible chance to stay healthy and delay full Type 1 diabetes.